Updated Efficacy, Safety and Dosing Management of Poziotinib in Previously Treated EGFR and HER2 Exon 20 NSCLC Patients Meeting Abstract

International Collaboration

cited authors

  • Cornelissen, R.; Garassino, M. C.; Le, X.; Clarke, J.; Tchekmedyian, N.; Goldman, J.; Lebel, F.; Bhat, G.; Socinski, M.

authors

Publication Date

  • March 1, 2021

webpage

published in

category

keywords

  • Exon 20
  • NSCLC
  • Poziotinib

start page

  • S173

end page

  • S174

volume

  • 16

issue

  • 3